SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-070166
Filing Date
2023-03-14
Accepted
2023-03-14 16:18:58
Documents
14
Period of Report
2023-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d464597d8k.htm   iXBRL 8-K 25139
2 EX-99.1 d464597dex991.htm EX-99.1 93197
6 GRAPHIC g464597g73t31.jpg GRAPHIC 10382
  Complete submission text file 0001193125-23-070166.txt   260444

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20230314.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20230314_lab.xml EX-101.LAB 17911
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20230314_pre.xml EX-101.PRE 11239
8 EXTRACTED XBRL INSTANCE DOCUMENT d464597d8k_htm.xml XML 3330
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 23731255
SIC: 2834 Pharmaceutical Preparations